Aspiriant LLC lowered its stake in shares of The Procter & Gamble Company (NYSE:PG – Free Report) by 2.8% in the 1st quarter, according to the company in its most recent disclosure with the SEC. The firm owned 30,145 shares of the company’s stock after selling 855 shares during the quarter. Aspiriant LLC’s holdings in Procter & Gamble were worth $4,482,000 as of its most recent SEC filing.
Several other institutional investors also recently added to or reduced their stakes in the stock. EWG Elevate Inc. bought a new position in Procter & Gamble during the fourth quarter worth about $26,000. Silicon Valley Capital Partners bought a new position in shares of Procter & Gamble in the fourth quarter valued at approximately $28,000. IAG Wealth Partners LLC boosted its position in shares of Procter & Gamble by 58.8% in the first quarter. IAG Wealth Partners LLC now owns 243 shares of the company’s stock valued at $36,000 after acquiring an additional 90 shares during the period. Luken Investment Analytics LLC bought a new position in shares of Procter & Gamble in the fourth quarter valued at approximately $37,000. Finally, Bourgeon Capital Management LLC boosted its position in shares of Procter & Gamble by 39.9% in the fourth quarter. Bourgeon Capital Management LLC now owns 249 shares of the company’s stock valued at $38,000 after acquiring an additional 71 shares during the period. Institutional investors own 64.65% of the company’s stock.
Insider Activity
In related news, insider Susan Street Whaley sold 4,852 shares of the business’s stock in a transaction that occurred on Wednesday, April 26th. The stock was sold at an average price of $155.47, for a total transaction of $754,340.44. Following the completion of the transaction, the insider now directly owns 7,977 shares in the company, valued at approximately $1,240,184.19. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. In other Procter & Gamble news, insider Susan Street Whaley sold 4,852 shares of the company’s stock in a transaction that occurred on Wednesday, April 26th. The stock was sold at an average price of $155.47, for a total value of $754,340.44. Following the completion of the transaction, the insider now directly owns 7,977 shares in the company, valued at approximately $1,240,184.19. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO Ma. Fatima Francisco sold 8,000 shares of the company’s stock in a transaction that occurred on Monday, April 24th. The stock was sold at an average price of $156.84, for a total value of $1,254,720.00. Following the completion of the transaction, the chief executive officer now owns 9,343 shares of the company’s stock, valued at $1,465,356.12. The disclosure for this sale can be found here. Insiders sold 95,093 shares of company stock valued at $14,821,930 in the last quarter. 0.26% of the stock is currently owned by insiders.
Procter & Gamble Price Performance
Procter & Gamble (NYSE:PG – Get Free Report) last issued its earnings results on Friday, April 21st. The company reported $1.37 earnings per share for the quarter, topping analysts’ consensus estimates of $1.32 by $0.05. Procter & Gamble had a return on equity of 32.18% and a net margin of 17.69%. The business had revenue of $20.07 billion during the quarter, compared to analyst estimates of $19.32 billion. During the same quarter in the previous year, the firm earned $1.33 EPS. Procter & Gamble’s revenue was up 3.5% on a year-over-year basis. Sell-side analysts predict that The Procter & Gamble Company will post 5.86 earnings per share for the current fiscal year.
Procter & Gamble Dividend Announcement
The firm also recently declared a quarterly dividend, which will be paid on Tuesday, August 15th. Stockholders of record on Friday, July 21st will be given a dividend of $0.9407 per share. This represents a $3.76 annualized dividend and a dividend yield of 2.51%. The ex-dividend date is Thursday, July 20th. Procter & Gamble’s payout ratio is currently 65.51%.
Wall Street Analysts Forecast Growth
A number of equities analysts have recently commented on the stock. Truist Financial lowered shares of Procter & Gamble from a “buy” rating to a “hold” rating and cut their price objective for the company from $165.00 to $155.00 in a research report on Thursday, May 18th. Evercore ISI raised their target price on shares of Procter & Gamble from $160.00 to $170.00 and gave the company an “outperform” rating in a research note on Monday, April 24th. Barclays raised their target price on shares of Procter & Gamble from $160.00 to $167.00 in a research note on Wednesday, April 26th. StockNews.com initiated coverage on shares of Procter & Gamble in a research note on Thursday, May 18th. They issued a “buy” rating on the stock. Finally, Royal Bank of Canada raised their target price on shares of Procter & Gamble from $160.00 to $165.00 and gave the company a “sector perform” rating in a research note on Monday, April 24th. Five investment analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $161.50.
Procter & Gamble Company Profile
The Procter & Gamble Company provides branded consumer packaged goods worldwide. It operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, and SK-II brands.
Further Reading
- Five stocks we like better than Procter & Gamble
- MarketBeat Week in Review – 7/10 – 7/14
- Wells Fargo’s Earnings, Why Markets Are Loving The Stock
- Citigroup Leads Banking Earnings, What’s Next?
- BlackRock Kicks Off Financials Earnings Season, Gauge To Markets
- JPMorgan Chase Is In Reversal But Don’t Chase It Higher
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.